Eugene Mah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eugene Mah has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Hai Yao
Department of Bioengineering, Clemson University, Clemson, USA
3 shared publications Walter Huda
Department of Radiology and Radiological Science, Medical University of South Carolina (MUSC), Charleston, SC 29425, USA
2 shared publications- Alexander M. Chiaramonti
Department of Orthopaedic Surgery and Rehabilitation, Wake Forest University School of Medicine, Winston Salem, NC USA
1 shared publication - Claire Sumwalt
Department of Bioengineering, Clemson University 68 President Street, BEB 203, Charleston, SC 29425 USA
1 shared publication - Dane N. Daley
Medical University of South Carolina, Charleston, USA
1 shared publication - Daniel Gordon
Department of Bioengineering, Clemson University 68 President Street, BEB 203, Charleston, SC 29425 USA
1 shared publication
Latest Publications
- 4 November 2025
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 34 (1) , 148-159
Association of ligament mechanical properties and articular surface topography with trapeziometacarpal kinematics across osteoarthritis stages
- 4 November 2025
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 34 (1) , 148-159
Association of ligament mechanical properties and articular surface topography with trapeziometacarpal kinematics across osteoarthritis stages
- 1 March 2021
- Published by Oxford University Press (OUP) in Dentomaxillofacial Radiology
- Vol. 50 (3) , 20200225
A review of dental cone-beam CT dose conversion coefficients
Objective: The purpose of this study was to review the literature to examine the usage and magnitude of effective dose conversion factors (DCE) for dental cone beam CT (CBCT) scanners.Methods: A PubMed literature search for publications relating to radiation dosimetry in dental radiography was performed. Papers were included if they reported DCE, or reported ICRP 103 effective dose and dose-area product. 71 papers relating to dental CBCT dosimetry were found, of which eight reported effective dose conversion factors or provided enough information to calculate dose conversion factors. Scanner model, effective dose, dose-area product, tube voltage, field of view size and DCEwere extracted from the papers for analysis.Results: DCEvalues ranged from 0.035 to 0.31 µSv/mGy-cm2with a mean of 0.129 µSv/mGy-cm2(SD = 0.056). When categorized into small (225 cm2) fields of view (FOV), linear fits to the effective dose and dose-area product yielded slopes of 0.129, 0.111 and 0.074 µSv/mGy-cm2for small, medium and large FOVs respectively.Conclusion: The range of reported DCEvalues and spread with respect to field of view category suggests that DCEvalues that depend on FOV would provide more accurate effective dose estimates. Tube voltage was found to be a smaller factor in determining DCE. Reasonable values for DCEtaking into account FOV size were obtained. There is considerable room for more work to be done to examine the behaviour of DCEwith changes to patient age and dental CBCT imaging parameters.
- 1 March 2021
- Published by Oxford University Press (OUP) in Dentomaxillofacial Radiology
- Vol. 50 (3) , 20200225
A review of dental cone-beam CT dose conversion coefficients
Objective: The purpose of this study was to review the literature to examine the usage and magnitude of effective dose conversion factors (DCE) for dental cone beam CT (CBCT) scanners.Methods: A PubMed literature search for publications relating to radiation dosimetry in dental radiography was performed. Papers were included if they reported DCE, or reported ICRP 103 effective dose and dose-area product. 71 papers relating to dental CBCT dosimetry were found, of which eight reported effective dose conversion factors or provided enough information to calculate dose conversion factors. Scanner model, effective dose, dose-area product, tube voltage, field of view size and DCEwere extracted from the papers for analysis.Results: DCEvalues ranged from 0.035 to 0.31 µSv/mGy-cm2with a mean of 0.129 µSv/mGy-cm2(SD = 0.056). When categorized into small (225 cm2) fields of view (FOV), linear fits to the effective dose and dose-area product yielded slopes of 0.129, 0.111 and 0.074 µSv/mGy-cm2for small, medium and large FOVs respectively.Conclusion: The range of reported DCEvalues and spread with respect to field of view category suggests that DCEvalues that depend on FOV would provide more accurate effective dose estimates. Tube voltage was found to be a smaller factor in determining DCE. Reasonable values for DCEtaking into account FOV size were obtained. There is considerable room for more work to be done to examine the behaviour of DCEwith changes to patient age and dental CBCT imaging parameters.
- 12 May 2014
- Published by Oxford University Press (OUP) in Radiation Protection Dosimetry
- Vol. 163 (2) , 251-260
Review of Kerma-Area Product and total energy incident on patients in radiography, mammography and CT
This study estimated the energy incident on patients in radiography, mammography and CT using data related to X-ray beam quantity and quality. The total X-ray beam quantity is the average Air Kerma multiplied by the X-ray beam area and expressed as the Kerma–Area Product (Gy cm−2). The X-ray beam quality primarily depends on the target material (and anode angle), X-ray voltage (and ripple) as well as X-ray beam filtration. For any X-ray spectra, dividing total energy (fluence × mean energy) by the X-ray beam Kerma–Area Product yields the energy per Kerma–Area Product value (ε/KAP). Published data on X-ray spectra characteristics and energy fluence per Air Kerma conversion factors were used to determine ε/KAP factors. In radiography, ε/KAP increased from 6 mJ Gy−1 cm−2 at the lowest X-ray tube voltage (50 kV) to 25 mJ Gy−1 cm−2 at the highest X-ray tube voltage (140 kV). ε/KAP values ranged between 1 and 5 mJ Gy−1 cm−2 in mammography and between 24 and 42 mJ Gy−1 cm−2 in CT. Changes in waveform ripple resulted in variations in ε/KAP of up to 15 %, similar to the effect of changes resulting in the choice of anode angle. For monoenergetic X-ray photons, there was a sigmoidal-type increase in ε/KAP from 2 mJ Gy−1 cm−2 at 20 keV to 42 mJ Gy−1 cm−2 at 80 keV. However, between 80 and 150 keV, the ε/KAP shows variations with changing photon energy of ε/KAP. This study illustrated that the energy incident on a patient in any area of radiological imaging can be estimated from the total X-ray beam intensity (KAP) when X-ray beam quality is taken into account. Energy incident on the patient can be used to estimate the energy absorbed by the patient and the corresponding patient effective dose.
- 12 May 2014
- Published by Oxford University Press (OUP) in Radiation Protection Dosimetry
- Vol. 163 (2) , 251-260
Review of Kerma-Area Product and total energy incident on patients in radiography, mammography and CT
This study estimated the energy incident on patients in radiography, mammography and CT using data related to X-ray beam quantity and quality. The total X-ray beam quantity is the average Air Kerma multiplied by the X-ray beam area and expressed as the Kerma–Area Product (Gy cm−2). The X-ray beam quality primarily depends on the target material (and anode angle), X-ray voltage (and ripple) as well as X-ray beam filtration. For any X-ray spectra, dividing total energy (fluence × mean energy) by the X-ray beam Kerma–Area Product yields the energy per Kerma–Area Product value (ε/KAP). Published data on X-ray spectra characteristics and energy fluence per Air Kerma conversion factors were used to determine ε/KAP factors. In radiography, ε/KAP increased from 6 mJ Gy−1 cm−2 at the lowest X-ray tube voltage (50 kV) to 25 mJ Gy−1 cm−2 at the highest X-ray tube voltage (140 kV). ε/KAP values ranged between 1 and 5 mJ Gy−1 cm−2 in mammography and between 24 and 42 mJ Gy−1 cm−2 in CT. Changes in waveform ripple resulted in variations in ε/KAP of up to 15 %, similar to the effect of changes resulting in the choice of anode angle. For monoenergetic X-ray photons, there was a sigmoidal-type increase in ε/KAP from 2 mJ Gy−1 cm−2 at 20 keV to 42 mJ Gy−1 cm−2 at 80 keV. However, between 80 and 150 keV, the ε/KAP shows variations with changing photon energy of ε/KAP. This study illustrated that the energy incident on a patient in any area of radiological imaging can be estimated from the total X-ray beam intensity (KAP) when X-ray beam quality is taken into account. Energy incident on the patient can be used to estimate the energy absorbed by the patient and the corresponding patient effective dose.
- 1 February 2011
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 196 (2) , W159-W165
Radiation-Related Cancer Risks in a Clinical Patient Population Undergoing Cardiac CT
OBJECTIVE. The purpose of our study was to estimate cancer induction risk and generate risk conversion factors in cardiac CT angiography.MATERIALS AND METHODS. Under an institutional review board waiver and in compliance with HIPAA, we collected characteristics for a consecutive cohort of 100 patients (60 men and 40 women; mean age, 59 ± 11 years) who had previously undergone ECG-gated cardiac CT angiography on a 64-slice CT scanner. The volume CT Dose Index (CTDIvol) and dose-length product (DLP) were recorded and used with the ImPACT CT Patient Dosimetry Calculator to compute organ and effective doses in a standard 70 kg phantom. Patient-specific organ and effective doses were obtained by applying a weight-based correction factor. Radiation doses to radiosensitive organs were converted to risks using age- and sex-specific data published in BEIR VII.RESULTS. Median values were 62 mGy for CTDIvol, 1,084 mGy-cm for DLP, and 17 cm for scan length. Effective doses ranged from 20 mSv (10th percentile) to 31 m...
- 1 February 2011
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 196 (2) , W159-W165
Radiation-Related Cancer Risks in a Clinical Patient Population Undergoing Cardiac CT
OBJECTIVE. The purpose of our study was to estimate cancer induction risk and generate risk conversion factors in cardiac CT angiography.MATERIALS AND METHODS. Under an institutional review board waiver and in compliance with HIPAA, we collected characteristics for a consecutive cohort of 100 patients (60 men and 40 women; mean age, 59 ± 11 years) who had previously undergone ECG-gated cardiac CT angiography on a 64-slice CT scanner. The volume CT Dose Index (CTDIvol) and dose-length product (DLP) were recorded and used with the ImPACT CT Patient Dosimetry Calculator to compute organ and effective doses in a standard 70 kg phantom. Patient-specific organ and effective doses were obtained by applying a weight-based correction factor. Radiation doses to radiosensitive organs were converted to risks using age- and sex-specific data published in BEIR VII.RESULTS. Median values were 62 mGy for CTDIvol, 1,084 mGy-cm for DLP, and 17 cm for scan length. Effective doses ranged from 20 mSv (10th percentile) to 31 m...
- Open Access
- 1 September 2007
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine Technology
- Vol. 35 (3) , 148-153
Comparison of Medium- and High-Energy Collimators for 131I-Tositumomab Dosimetry
Residence time measurements obtained by serial whole-body conjugate-view imaging are commonly used in patient-specific dosimetry for radioimmunotherapy applications. In order to determine the effect of collimator selection on residence time measurements for 131I, the accuracies of 131I half-life measurements obtained with multiple γ-camera and collimator combinations were investigated. Methods: Serial anterior and posterior whole-body images were acquired over a period of 15 d with 4 different γ-cameras and medium- or high-energy collimators. Background-corrected geometric mean counts from the images were fitted to a monoexponential curve to determine the half-life of 131I obtained with the different γ-camera and collimator combinations. Results: An average half-life of 8.15 d (SD, 0.07 d) was obtained with all γ-camera and collimator combinations. A half-life of 8.12 d (SD, 0.11 d) was obtained with the high-energy collimators, and a half-life of 8.18 d (SD, 0.04 d) was obtained with the medium-energy collimators. These values are all very close to the 131I physical half-life of 8.02 d and were not found to be statistically significantly different (P = 0.44). Similar results were obtained for the half-life obtained with single-head γ-camera configurations (mean half-life, 8.15 d; SD, 0.12 d). The therapeutic 131I-tositumomab dose resulting from the differences in the measured half-life ranged from 2.58 to 2.6 GBq (69.8–70.4 mCi). Conclusion: There is no significant difference in 131I half-life and residence time measurements obtained with medium- or high-energy collimators in dual-head or single-head imaging configurations.
- 1 September 2007
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine Technology
- Vol. 35 (3) , 148-153
Open AccessComparison of Medium- and High-Energy Collimators for 131I-Tositumomab Dosimetry
Residence time measurements obtained by serial whole-body conjugate-view imaging are commonly used in patient-specific dosimetry for radioimmunotherapy applications. In order to determine the effect of collimator selection on residence time measurements for 131I, the accuracies of 131I half-life measurements obtained with multiple γ-camera and collimator combinations were investigated. Methods: Serial anterior and posterior whole-body images were acquired over a period of 15 d with 4 different γ-cameras and medium- or high-energy collimators. Background-corrected geometric mean counts from the images were fitted to a monoexponential curve to determine the half-life of 131I obtained with the different γ-camera and collimator combinations. Results: An average half-life of 8.15 d (SD, 0.07 d) was obtained with all γ-camera and collimator combinations. A half-life of 8.12 d (SD, 0.11 d) was obtained with the high-energy collimators, and a half-life of 8.18 d (SD, 0.04 d) was obtained with the medium-energy collimators. These values are all very close to the 131I physical half-life of 8.02 d and were not found to be statistically significantly different (P = 0.44). Similar results were obtained for the half-life obtained with single-head γ-camera configurations (mean half-life, 8.15 d; SD, 0.12 d). The therapeutic 131I-tositumomab dose resulting from the differences in the measured half-life ranged from 2.58 to 2.6 GBq (69.8–70.4 mCi). Conclusion: There is no significant difference in 131I half-life and residence time measurements obtained with medium- or high-energy collimators in dual-head or single-head imaging configurations.
- Open Access
- 1 March 2001
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 2 (2) , 90-101
Evaluation of a quality control phantom for digital chest radiography
Evaluation of a quality control phantom for digital chest radiography
- 1 March 2001
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 2 (2) , 90-101
Open AccessEvaluation of a quality control phantom for digital chest radiography
Evaluation of a quality control phantom for digital chest radiography